These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 14592559

  • 1. Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.
    Jastrzebska M, Goracy I, Naruszewicz M.
    Thromb Res; 2003 Jun 15; 110(5-6):339-44. PubMed ID: 14592559
    [Abstract] [Full Text] [Related]

  • 2. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan 15; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 3. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Jan 15; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul 15; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 5. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M, Widecka K, Naruszewicz M, Ciechanowicz A, Janczak-Bazan A, Foltynska A, Goracy I, Chetstowski K, Wesotowska T.
    Nutr Metab Cardiovasc Dis; 2004 Oct 15; 14(5):259-69. PubMed ID: 15673060
    [Abstract] [Full Text] [Related]

  • 6. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.
    Ophthalmic Genet; 2018 Dec 15; 39(6):714-716. PubMed ID: 30442055
    [Abstract] [Full Text] [Related]

  • 7. Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
    Kim HS, Hwang KY, Chung IK, Park SH, Lee MH, Kim SJ, Hong SY.
    J Korean Med Sci; 2003 Feb 15; 18(1):58-64. PubMed ID: 12589088
    [Abstract] [Full Text] [Related]

  • 8. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Feb 15; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 9. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr 15; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 10. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R, Liu Z, Chen Z, Li L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb 15; 19(1):1-5. PubMed ID: 11836675
    [Abstract] [Full Text] [Related]

  • 11. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
    Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ.
    Chin Med J (Engl); 2012 Apr 15; 125(7):1249-53. PubMed ID: 22613596
    [Abstract] [Full Text] [Related]

  • 12. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.
    Genet Test Mol Biomarkers; 2010 Feb 15; 14(1):23-7. PubMed ID: 19929406
    [Abstract] [Full Text] [Related]

  • 13. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
    Gong R, Liu Z, Li L.
    Arthritis Rheum; 2007 May 15; 56(5):1608-17. PubMed ID: 17469143
    [Abstract] [Full Text] [Related]

  • 14. Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction.
    Ahmed W, Malik M, Saeed I, Khan AA, Sadeque A, Kaleem U, Ahmed N, Ajmal M, Azam M, Qamar R.
    Mol Biol Rep; 2011 Apr 15; 38(4):2541-8. PubMed ID: 21082259
    [Abstract] [Full Text] [Related]

  • 15. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 15; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 16. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.
    Thromb Res; 2012 Sep 15; 130(3):e43-51. PubMed ID: 22771216
    [Abstract] [Full Text] [Related]

  • 17. Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.
    Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T.
    Am J Hypertens; 2011 Jul 15; 24(7):802-8. PubMed ID: 21490692
    [Abstract] [Full Text] [Related]

  • 18. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
    Ozolina A, Strike E, Jaunalksne I, Serova J, Romanova T, Zake LN, Sabelnikovs O, Vanags I.
    Medicina (Kaunas); 2012 Jul 15; 48(10):515-20. PubMed ID: 23324247
    [Abstract] [Full Text] [Related]

  • 19. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
    Seguí R, Estellés A, Mira Y, España F, Villa P, Falcó C, Vayá A, Grancha S, Ferrando F, Aznar J.
    Br J Haematol; 2000 Oct 15; 111(1):122-8. PubMed ID: 11091191
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 15; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.